Advancements in the Treatment and Prevention of Breast Cancer highlights the significance of early detection, risk assessment, and comprehensive care in mitigating the burden of breast cancer within communities. It not only offers insights into the genetic basis of breast cancer susceptibility, familial risk assessment, and emerging genetic testing technologies but also empowers patients and their families with knowledge about available treatment options, clinical trials, and support resources.
In 14 chapters this book provides an in-depth analysis of translational research focusing on understanding the etiology of breast cancer, elucidating potential avenues for primary prevention strategies. It offers a comprehensive overview of recent breakthroughs in understanding the molecular mechanisms underlying breast cancer development and discussing novel targeted treatment approaches derived from these advances but also discusses strategies for minimizing treatment-related toxicity in breast cancer management, including supportive care measures and personalized treatment approaches. This book is a valuable resource for anyone interested in the latest developments in breast cancer care and provides clear explanations of complex scientific topics and will offer insights that can help improve patient care and outcomes.
1. Translational Perspectives on Breast Cancer Etiology: Opportunities
for Primary Prevention
2. Recent Advances in the Molecular Pathogenesis and Targeted Treatment of
Breast Cancer
3. Precision Medicine Approaches and the Management of Triple-negative Breast
Cancer
4. Multigene Assays for Prognosis and Prediction in Breast Cancer
5. Progress in Immunotherapy and Vaccine Development for Breast Malignancies
6. Emerging Imaging Biomarkers for Screening, Staging, and Treatment Response
in Breast Cancer
7. Advancements in Risk-Stratified Early Detection Strategies for Breast
Cancer
8. Innovations in Oncoplastic and Reconstructive Techniques Post Breast
Cancer Therapy
9. CD4-6K Inhibitors for the Treatment of Breast Cancer
10. Disparities in Breast Cancer Incidence, Diagnosis, and Outcomes: Current
Status and Future Directions
11. Elucidating Mechanisms of Endocrine Resistance in Estrogen
Receptor-Positive Breast Cancer
12. Metastatic Breast Cancer in the Era of Targeted Systemic and Localized
Therapies
13. Mitigating Treatment-Related Toxicity in Breast Cancer Management
14. Multimodal Therapies for Residual, Recurrent, and Metastatic Breast Cancer
Dileep Kumar received his B. Pharm from Manipal College of Pharmaceutical Sciences, Manipal University, and M. Pharm from S.G.S.I.T.S Indore, Madhya Pradesh. He has several patents to his credit. He was awarded a Junior Research fellowship by National Medicinal Plant Board (NMPB) New Delhi, Senior Research Fellowship from University Grants Commission (UGC), Teaching Assistantship, and institute Post-Doctoral fellowship from IIT (BHU) Varanasi. At present, he is teaching as an assistant professor at Poona College of pharmacy, Bharti Vidyapeeth University Pune. He has published many papers and patents. He is Guest editor of several Prestigious journals. At present he is visiting professor in the department of entomology and Comprehensive Cancer Center in university of California Davis
